Lung Cancer
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolle ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lower GI Series Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Double-Contrast 1.2.3 Single-Contrast 1.3 Market by Application 1.3.1 Global Lower GI Series Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lower GI Series Market Perspective (2016-2027) 2.2 Lower GI Series Growth Trends by Regions 2.2.1 Lower GI Series Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Lower GI Series Historic Market Share by Regions (2016-2021) 2.2.3 Lower GI Series Forecasted Market Size by Regions (2022-2027) 2.3 Lower GI Series Industry Dynamic 2.3.1 Lower GI Series Market Trends 2.3.2 Lower GI Series Market Drivers 2.3.3 Lower GI Series Market Challenges 2.3.4 Lower GI Series Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lower GI Series Players by Revenue 3.1.1 Global Top Lower GI Series Players by Revenue (2016-2021) 3.1.2 Global Lower GI Series Revenue Market Share by Players (2016-2021) 3.2 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Lower GI Series Revenue 3.4 Global Lower GI Series Market Concentration Ratio 3.4.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2020 3.5 Lower GI Series Key Players Head office and Area Served 3.6 Key Players Lower GI Series Product Solution and Service 3.7 Date of Enter into Lower GI Series Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lower GI Series Breakdown Data by Type 4.1 Global Lower GI Series Historic Market Size by Type (2016-2021) 4.2 Global Lower GI Series Forecasted Market Size by Type (2022-2027) 5 Lower GI Series Breakdown Data by Application 5.1 Global Lower GI Series Historic Market Size by Application (2016-2021) 5.2 Global Lower GI Series Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Lower GI Series Market Size (2016-2027) 6.2 North America Lower GI Series Market Size by Type 6.2.1 North America Lower GI Series Market Size by Type (2016-2021) 6.2.2 North America Lower GI Series Market Size by Type (2022-2027) 6.2.3 North America Lower GI Series Market Size by Type (2016-2027) 6.3 North America Lower GI Series Market Size by Application 6.3.1 North America Lower GI Series Market Size by Application (2016-2021) 6.3.2 North America Lower GI Series Market Size by Application (2022-2027) 6.3.3 North America Lower GI Series Market Size by Application (2016-2027) 6.4 North America Lower GI Series Market Size by Country 6.4.1 North America Lower GI Series Market Size by Country (2016-2021) 6.4.2 North America Lower GI Series Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Lower GI Series Market Size (2016-2027) 7.2 Europe Lower GI Series Market Size by Type 7.2.1 Europe Lower GI Series Market Size by Type (2016-2021) 7.2.2 Europe Lower GI Series Market Size by Type (2022-2027) 7.2.3 Europe Lower GI Series Market Size by Type (2016-2027) 7.3 Europe Lower GI Series Market Size by Application 7.3.1 Europe Lower GI Series Market Size by Application (2016-2021) 7.3.2 Europe Lower GI Series Market Size by Application (2022-2027) 7.3.3 Europe Lower GI Series Market Size by Application (2016-2027) 7.4 Europe Lower GI Series Market Size by Country 7.4.1 Europe Lower GI Series Market Size by Country (2016-2021) 7.4.2 Europe Lower GI Series Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Lower GI Series Market Size (2016-2027) 8.2 Asia-Pacific Lower GI Series Market Size by Type 8.2.1 Asia-Pacific Lower GI Series Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Lower GI Series Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Lower GI Series Market Size by Type (2016-2027) 8.3 Asia-Pacific Lower GI Series Market Size by Application 8.3.1 Asia-Pacific Lower GI Series Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Lower GI Series Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Lower GI Series Market Size by Application (2016-2027) 8.4 Asia-Pacific Lower GI Series Market Size by Region 8.4.1 Asia-Pacific Lower GI Series Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Lower GI Series Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Lower GI Series Market Size (2016-2027) 9.2 Latin America Lower GI Series Market Size by Type 9.2.1 Latin America Lower GI Series Market Size by Type (2016-2021) 9.2.2 Latin America Lower GI Series Market Size by Type (2022-2027) 9.2.3 Latin America Lower GI Series Market Size by Type (2016-2027) 9.3 Latin America Lower GI Series Market Size by Application 9.3.1 Latin America Lower GI Series Market Size by Application (2016-2021) 9.3.2 Latin America Lower GI Series Market Size by Application (2022-2027) 9.3.3 Latin America Lower GI Series Market Size by Application (2016-2027) 9.4 Latin America Lower GI Series Market Size by Country 9.4.1 Latin America Lower GI Series Market Size by Country (2016-2021) 9.4.2 Latin America Lower GI Series Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lower GI Series Market Size (2016-2027) 10.2 Middle East & Africa Lower GI Series Market Size by Type 10.2.1 Middle East & Africa Lower GI Series Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Lower GI Series Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Lower GI Series Market Size by Type (2016-2027) 10.3 Middle East & Africa Lower GI Series Market Size by Application 10.3.1 Middle East & Africa Lower GI Series Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Lower GI Series Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Lower GI Series Market Size by Application (2016-2027) 10.4 Middle East & Africa Lower GI Series Market Size by Country 10.4.1 Middle East & Africa Lower GI Series Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Lower GI Series Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eisai 11.1.1 Eisai Company Details 11.1.2 Eisai Business Overview 11.1.3 Eisai Lower GI Series Introduction 11.1.4 Eisai Revenue in Lower GI Series Business (2016-2021) 11.1.5 Eisai Recent Development 11.2 Cadila Pharmaceuticals 11.2.1 Cadila Pharmaceuticals Company Details 11.2.2 Cadila Pharmaceuticals Business Overview 11.2.3 Cadila Pharmaceuticals Lower GI Series Introduction 11.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) 11.2.5 Cadila Pharmaceuticals Recent Development 11.3 Purdue Pharma 11.3.1 Purdue Pharma Company Details 11.3.2 Purdue Pharma Business Overview 11.3.3 Purdue Pharma Lower GI Series Introduction 11.3.4 Purdue Pharma Revenue in Lower GI Series Business (2016-2021) 11.3.5 Purdue Pharma Recent Development 11.4 Peacehealth 11.4.1 Peacehealth Company Details 11.4.2 Peacehealth Business Overview 11.4.3 Peacehealth Lower GI Series Introduction 11.4.4 Peacehealth Revenue in Lower GI Series Business (2016-2021) 11.4.5 Peacehealth Recent Development 11.5 Novadaq 11.5.1 Novadaq Company Details 11.5.2 Novadaq Business Overview 11.5.3 Novadaq Lower GI Series Introduction 11.5.4 Novadaq Revenue in Lower GI Series Business (2016-2021) 11.5.5 Novadaq Recent Development 11.6 Astrazeneca 11.6.1 Astrazeneca Company Details 11.6.2 Astrazeneca Business Overview 11.6.3 Astrazeneca Lower GI Series Introduction 11.6.4 Astrazeneca Revenue in Lower GI Series Business (2016-2021) 11.6.5 Astrazeneca Recent Development 11.7 Ironwood Pharmaceuticals 11.7.1 Ironwood Pharmaceuticals Company Details 11.7.2 Ironwood Pharmaceuticals Business Overview 11.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction 11.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) 11.7.5 Ironwood Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Lower GI Series Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Double-Contrast Table 3. Key Players of Single-Contrast Table 4. Global Lower GI Series Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Lower GI Series Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Lower GI Series Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Lower GI Series Market Share by Regions (2016-2021) Table 8. Global Lower GI Series Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Lower GI Series Market Share by Regions (2022-2027) Table 10. Lower GI Series Market Trends Table 11. Lower GI Series Market Drivers Table 12. Lower GI Series Market Challenges Table 13. Lower GI Series Market Restraints Table 14. Global Lower GI Series Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Lower GI Series Market Share by Players (2016-2021) Table 16. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2020) Table 17. Ranking of Global Top Lower GI Series Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Lower GI Series Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Lower GI Series Product Solution and Service Table 21. Date of Enter into Lower GI Series Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 24. Global Lower GI Series Revenue Market Share by Type (2016-2021) Table 25. Global Lower GI Series Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Lower GI Series Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Lower GI Series Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Lower GI Series Revenue Market Share by Application (2016-2021) Table 29. Global Lower GI Series Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Lower GI Series Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 32. North America Lower GI Series Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Lower GI Series Market Size by Application (2016-2021) (US$ Million) Table 34. North America Lower GI Series Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Lower GI Series Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Lower GI Series Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Lower GI Series Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Lower GI Series Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Lower GI Series Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Lower GI Series Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Lower GI Series Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Lower GI Series Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Lower GI Series Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Lower GI Series Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Lower GI Series Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Lower GI Series Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Lower GI Series Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Lower GI Series Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Lower GI Series Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Lower GI Series Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Lower GI Series Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Lower GI Series Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Lower GI Series Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Lower GI Series Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Lower GI Series Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Lower GI Series Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Lower GI Series Market Size by Country (2022-2027) & (US$ Million) Table 61. Eisai Company Details Table 62. Eisai Business Overview Table 63. Eisai Lower GI Series Product Table 64. Eisai Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 65. Eisai Recent Development Table 66. Cadila Pharmaceuticals Company Details Table 67. Cadila Pharmaceuticals Business Overview Table 68. Cadila Pharmaceuticals Lower GI Series Product Table 69. Cadila Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 70. Cadila Pharmaceuticals Recent Development Table 71. Purdue Pharma Company Details Table 72. Purdue Pharma Business Overview Table 73. Purdue Pharma Lower GI Series Product Table 74. Purdue Pharma Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 75. Purdue Pharma Recent Development Table 76. Peacehealth Company Details Table 77. Peacehealth Business Overview Table 78. Peacehealth Lower GI Series Product Table 79. Peacehealth Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 80. Peacehealth Recent Development Table 81. Novadaq Company Details Table 82. Novadaq Business Overview Table 83. Novadaq Lower GI Series Product Table 84. Novadaq Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 85. Novadaq Recent Development Table 86. Astrazeneca Company Details Table 87. Astrazeneca Business Overview Table 88. Astrazeneca Lower GI Series Product Table 89. Astrazeneca Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 90. Astrazeneca Recent Development Table 91. Ironwood Pharmaceuticals Company Details Table 92. Ironwood Pharmaceuticals Business Overview Table 93. Ironwood Pharmaceuticals Lower GI Series Product Table 94. Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) & (US$ Million) Table 95. Ironwood Pharmaceuticals Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Lower GI Series Market Share by Type: 2020 VS 2027 Figure 2. Double-Contrast Features Figure 3. Single-Contrast Features Figure 4. Global Lower GI Series Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Lower GI Series Report Years Considered Figure 9. Global Lower GI Series Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Lower GI Series Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Lower GI Series Market Share by Regions: 2020 VS 2027 Figure 12. Global Lower GI Series Market Share by Regions (2022-2027) Figure 13. Global Lower GI Series Market Share by Players in 2020 Figure 14. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Lower GI Series Revenue in 2020 Figure 16. Global Lower GI Series Revenue Market Share by Type (2016-2021) Figure 17. Global Lower GI Series Revenue Market Share by Type (2022-2027) Figure 18. North America Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Lower GI Series Market Share by Type (2016-2027) Figure 20. North America Lower GI Series Market Share by Application (2016-2027) Figure 21. North America Lower GI Series Market Share by Country (2016-2027) Figure 22. United States Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Lower GI Series Market Share by Type (2016-2027) Figure 26. Europe Lower GI Series Market Share by Application (2016-2027) Figure 27. Europe Lower GI Series Market Share by Country (2016-2027) Figure 28. Germany Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Lower GI Series Market Share by Type (2016-2027) Figure 36. Asia-Pacific Lower GI Series Market Share by Application (2016-2027) Figure 37. Asia-Pacific Lower GI Series Market Share by Region (2016-2027) Figure 38. China Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Lower GI Series Market Share by Type (2016-2027) Figure 46. Latin America Lower GI Series Market Share by Application (2016-2027) Figure 47. Latin America Lower GI Series Market Share by Country (2016-2027) Figure 48. Mexico Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Lower GI Series Market Share by Type (2016-2027) Figure 52. Middle East & Africa Lower GI Series Market Share by Application (2016-2027) Figure 53. Middle East & Africa Lower GI Series Market Share by Country (2016-2027) Figure 54. Turkey Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Eisai Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 58. Cadila Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 59. Purdue Pharma Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 60. Peacehealth Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 61. Novadaq Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 62. Astrazeneca Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 63. Ironwood Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed
Eisai Cadila Pharmaceuticals Purdue Pharma Peacehealth Novadaq Astrazeneca Ironwood Pharmaceuticals
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolle ... Read More
Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absor ... Read More
Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have t ... Read More
Managed Pressure Drilling (MPD) is defined by the International Association of Drilling Contracto ... Read More